References
- Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
- Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA. 2011;305:1119–1127
- Kong X, Zhang L, Zhang L, et al. Mineral and bone disorder in Chinese dialysis patients: A multicenter study. BMC Nephrol. 2012;13:116
- Xu J, Zhang YX, Yu XQ, et al. Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: Multicenter, double blind, randomized, controlled trial in mainland China. BMC Nephrol. 2013;14:29
- Cupisti A, Morelli E, D’Alessandro C, Lupetti S, Barsotti G. Phosphate control in chronic uremia: Don’t forget diet. J Nephrol. 2003;16:29–33
- Moe SM, Drüeke TB, Block GA, et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1–S130
- Sun CY, Chang KC, Chen SH, Chang CT, Wu MS. Patient education: An efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. Ren Fail. 2008;30:57–62
- Ford JC, Pope JF, Hunt AE, Gerald B. The effect of diet education on the laboratory values and knowledge of hemodialysis patients with hyperphosphatemia. J Ren Nutr. 2004;14:36–44
- Yokum D, Glass G, Cheung CF, Cunningham J, Fan S, Madden AM. Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients. J Ren Nutr. 2008;18:521–529
- Caldeira D, Amaral T, David C, Sampaio C. Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: Systematic review with meta-analysis. J Ren Nutr. 2011;21:285–294
- Cupisti A, D’Alessandro C, Baldi R, Barsotti G. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia. J Ren Nutr. 2004;14:220–225
- Blaszak RT, Mitsnefes MM, Ilyas M, Salman SD, Belcher SM, Brady DR. Hyperphosphatemia in children receiving peritoneal dialysis – An educational program. Pediatr Nephrol. 2005;20:967–971
- Poduval RD, Wolgemuth C, Ferrell J, Hammes MS. Hyperphosphatemia in dialysis patients: Is there a role for focused counseling. J Ren Nutr. 2003;13:219–223
- Shenghong Z, Dequan H. The spatial distribution and group characteristic of Chinese Hakkas. Study of Ethnics in Guangxi. 2007;4:80–85
- Liu ZH. Nephrology in china. Nat Rev Nephrol. 2013;9:523–528
- Zhan JG. The distribution of Hakka in Guangdong and its effect on Hakka culture development. Acad Search Truth Reality. 2012;4:87–93 (in Chinese)
- Wang L, Li GS, Liu ZH. Guidance for diagnosis and treatment of mineral and bone disorder in chronic kidney disease. Chin J Nephrol Dial Transplant. 2013;06:554–559 (in Chinese)
- National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–S201
- Luo SF. Inheritance and evolution of Hakka dietary culture. Jiangxi Food Industry. 2009;03:20–23 (in Chinese)
- Li B. On the impact of geographical environment upon Hakka food culture. J Jiaying Univ. 2009;03:113–115 (in Chinese)
- Ashurst IB, Dobbie H. A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients. J Ren Nutr. 2003;13:267–274
- Reddy V, Symes F, Sethi N, et al. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population. J Ren Nutr. 2009;19:314–320
- Harris AD, McGregor JC, Perencevich EN, et al. The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc. 2006;13:16–23